ACLY and nasopharyngeal carcinoma: We took advantage of a transgene expressing Cre-recombinase under the control of the Six2 promoter to remove Acly from the Six2 expressing NPC population (Six2Cre::Acly-/-) in the developing kidney (Fig. 7a).